Mechanistically, it is a long-acting synthetic corticosteroid that decreases microvascular permeability by reducing vascular response to and expression of tumor-derived permeability factors like vascular endothelial growth factor (VEGF) (14–16). The gene discussed is VEGFA; the disease is neoplasm.